Passa alla casella di ricercaPassa alla navigazionePassa al contenuto principale

Capsaicin Nanoparticles as Therapeutic Agents against Gliomas

  • Evelin Martínez-Benavidez
    ,
  • ,
  • Sara Elisa Herrera-Rodríguez
    ,
  • Ofelia Yadira Lugo-Melchor(corresponding author)
    ,
  • Francisco Martín Goycoolea
    ,
  • Francisco Javier Guerrero Jazo
*Corresponding author for this work
Research Output:
Contribution to journal
Review article
Peer review

Open Access

Publication Information

Tipo di output

Research Output:
Contribution to journal
Review article
Peer review

Lingua originale

English

Pagine da-a (Numero di pagine)

Pagine 433-445 (13 pagine)

Rivista (volume, numero edizione)

Nano Biomedicine and Engineering (Volume 13, Edizione 4)

Attività cardine della pubblicazione

  • Published - 01/01/2021

Stato pubblicazione

Published - 01/01/2021

Publication IDs

  • Scopus: 85123453698

Abstract

Capsaicin is an alkaloid molecule with outstanding biological activity. Several reports have shown that capsaicin exerts significant antitumoral effects in several cancer cell lines, including gliomas. However, its application has been very limited due to its hydrophobicity, low affinity, and short life span. Gliomas are a heterogeneous group of brain malignant tumors with increasing prevalence worldwide. Standard therapy against these tumors generally includes resection by surgery, radiation, and chemotherapy or their combination. However, elicitation of tumor resistance to chemical or radiation treatments remains one of the main challenges to be resolved, particularly in the case of glioblastomas. Nanotechnology is an innovative approach to the treatment of Central Nervous System diseases and especially to gliomas treatment. Indeed, the use of nanotherapeutic formulations offers several advantages over the conventional methods of drug delivery therapy. In this review, we analyzed the current literature regarding the development of capsaicin-loaded nanoparticles as a promising approach for the treatment of malignant brain tumors.